Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
TAKEDA PHARMACEUTICAL COMPANY LIMITED	1-1 DOSHOMACHI 4-CHOME CHUO-KU OSAKA-SHI OSAKA

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• C07D:HETEROCYCLIC COMPOUNDS

• [Classification Symbol]

• [Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Liu, Yi	San Diego, US	838	10296
Ren, Pingda	San Diego, US	198	6390
Wilson, Troy Edward	Rolling Hills Estates, US	58	2079

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Dec 7, 2027

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
June 07, 2016	US,9359349,B2   US9359349B2	GRANTED PATENT AS SECOND PUBLICATION
May 21, 2015	US,20150141442,A1   US20150141442A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9359349

Substituted quinazolines as kinase inhibitors

---

 

Legal Events